Advisor Partners’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
$1.77M Sell
18,635
-4,591
-20% -$437K 0.12% 176
2022
Q1
$2.73M Buy
23,226
+674
+3% +$79.3K 0.17% 113
2021
Q4
$2.92M Sell
22,552
-897
-4% -$116K 0.18% 105
2021
Q3
$2.66M Buy
23,449
+96
+0.4% +$10.9K 0.18% 105
2021
Q2
$2.42M Sell
23,353
-183
-0.8% -$19K 0.16% 123
2021
Q1
$1.97M Sell
23,536
-803
-3% -$67.2K 0.14% 148
2020
Q4
$2.22M Sell
24,339
-328
-1% -$29.9K 0.17% 123
2020
Q3
$1.97M Buy
24,667
+3,038
+14% +$243K 0.17% 117
2020
Q2
$1.5M Sell
21,629
-532
-2% -$36.8K 0.14% 148
2020
Q1
$1.39M Sell
22,161
-144
-0.6% -$9.05K 0.17% 127
2019
Q4
$1.76M Buy
22,305
+72
+0.3% +$5.68K 0.18% 127
2019
Q3
$1.63M Buy
22,233
+1,092
+5% +$80.1K 0.2% 111
2019
Q2
$1.3M Sell
21,141
-282
-1% -$17.4K 0.16% 122
2019
Q1
$1.37M Buy
21,423
+75
+0.4% +$4.78K 0.18% 111
2018
Q4
$1.09M Buy
21,348
+1,569
+8% +$80.1K 0.17% 125
2018
Q3
$1.15M Buy
19,779
+618
+3% +$35.9K 0.15% 129
2018
Q2
$930K Buy
19,161
+789
+4% +$38.3K 0.16% 148
2018
Q1
$854K Buy
18,372
+840
+5% +$39K 0.16% 144
2017
Q4
$724K Buy
17,532
+207
+1% +$8.55K 0.13% 184
2017
Q3
$631K Buy
17,325
+36
+0.2% +$1.31K 0.12% 181
2017
Q2
$681K Buy
17,289
+2,604
+18% +$103K 0.16% 159
2017
Q1
$460K Buy
14,685
+1,023
+7% +$32K 0.12% 211
2016
Q4
$427K Buy
13,662
+1,065
+8% +$33.3K 0.13% 194
2016
Q3
$506K Buy
12,597
+423
+3% +$17K 0.17% 148
2016
Q2
$405K Buy
12,174
+315
+3% +$10.5K 0.14% 170
2016
Q1
$349K Buy
11,859
+486
+4% +$14.3K 0.13% 191
2015
Q4
$299K Buy
11,373
+69
+0.6% +$1.81K 0.1% 208
2015
Q3
$268K Buy
11,304
+324
+3% +$7.68K 0.11% 213
2015
Q2
$261K Hold
10,980
0.1% 243
2015
Q1
$261K Buy
10,980
+1,386
+14% +$32.9K 0.11% 244
2014
Q4
$204K Buy
+9,594
New +$204K 0.09% 286